The articular lubricating fraction from bovine synovial fluid was prepared by repeated fractionation in three consecutive CsCl density gradients to remove completely traces of hyaluronic acid. The major glycoprotein consituent (LGP-I) was then isolated by repeated gel-permeation chromatography. The yield of the LGP-I component was about 20 mg/litre of synovial fluid. Sedimentation-equilibrium measurements showed that this glycoprotein was homogeneous and the mol.wt. was calculated to be 227500. Amino acids represented 43% (w/w) and carbohydrate constituents 44% (w/w) of the molecule. Threonine, glutamic acid, proline and lysine (224, 127, 242 and 128 residues/1000 residues respectively) were the major amino acids. Galactosamine, galactose and N-acetylneuraminic acid (202, 162 and 114 residues/molecule of LGP-I component respectively) accounted for 98% of the total carbohydrate residues present. Small amounts of mannose and glucosamine (1 and 9mol respectively/mol of LGP-I component) were also present. After treatment of LGP-I component with alkali and NaB3H4 radioactivity was incorporated into alpha-aminobutyric acid and alanine in a molar ratio of 4:1, and radioactive galactosaminitol was isolated by ion-exchange chromatography from a cleaved oligosaccharide fraction. These data demonstrate the presence of threonine and serine -O-GalNAc linkages, but only 25% of the theoretical likages involving threonine were cleaved by a beta-elimination reaction. Digestion of LGP-I component with Pronase followed by chromatography on DEAE-cellulose yielded glycopeptide fractions with a similar amino acid and carbohydrate composition to the intact molecule. Treatment of desialylated and intact LGP-I component with galactose oxidase followed by reduction with NaB3H4 revealed the presence of 52mol of terminal galactose in the intact molecule and 153mol of galactose/mol of LGP-I component after treatment with neuraminidase. The data indicate the LGP-I component is composed of a single polypeptide chain containg more than 150 oligaosaccharide side chains composed of O-GaINAc-Gal distributed over the length of the peptide chain and that terminal sialic acid residues are linked to galactose in two-thirds of these side chains.
Earlier studies have shown that the uptake of intact proteins from the intestinal lumen into the systemic circulation is increased in neonates. The present experiments tested the uptake of trypsin in newborn compared with 4-wk-old weaned rabbits. Trypsin (200 mg/100 g body wt) was administered by gavage to newborn and 4-wk-old rabbits. Four hours later, the tryptic activity and immunoreactive trypsin (i-trypsin) content of serum from newborn rabbits exceeded that of the older animals. After Sephadex G-200 gel filtration of serum from animals gavaged with trypsin, tryptic activity was detected in the excluded volume (presumably reflecting trypsin bound to alpha 2-macroglobulin), and i-trypsin was detected in the included volume (presumably reflecting trypsin bound to alpha 1-antitrypsin). In vitro experiments demonstrated that large amounts of trypsin were required to overwhelm the antiprotease present in normal rabbit serum. We suggest that complete or partial deficiencies of serum protease inhibitors may permit proteases taken up from the intestinal lumen of the neonate to circulate, reach the liver, and induce tissue injury at this site.
Glucocorticoids a r e known mediators of small i n t e s t i n a l matur a t i o n . I n t h i s s t u d y , t h e e f f e c t s of exogenously administered H C and PGI on BBMP and DNA s y n t h e s i s along with o t h e r i n d i c e s of maturatfon were evaluated. Suckling r a t s were administered
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.